Meridian Bioscience Market Cap 2006-2020 | VIVO

Meridian Bioscience market cap history and chart from 2006 to 2020. Market capitalization (or market value) is the most commonly used method of measuring the size of a publicly traded company and is calculated by multiplying the current stock price by the number of shares outstanding. Meridian Bioscience market cap as of August 11, 2020 is $0.75B.
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.750B $0.201B
Meridian Bioscience, Inc. is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and biopharmaceutical enabling technologies that help deliver answers. Its products provide accuracy, simplicity and speed for the early diagnosis and treatment of common medical conditions, such as C. difficile, H. pylori, foodborne diseases and respiratory infections. In addition, the company develops and manufactures a variety of biological and non-biological materials used in proficiency testing programs. Meridian diagnostic products are used outside of the human body and require little or no special equipment. Meridian Bioscience designs their products to enhance the well-being of the patient-while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal infections, serology, parasitology and fungal disease diagnosis.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $175.389B 32.91
Medtronic (MDT) Ireland $135.096B 21.94
Stryker (SYK) United States $70.813B 27.46
Boston Scientific (BSX) United States $56.240B 32.49
Lonza Group Ag (LZAGY) Switzerland $44.026B 0.00
Baxter (BAX) United States $41.987B 25.68
Terumo (TRUMY) Japan $29.409B 37.59
Zimmer Biomet Holdings (ZBH) United States $28.616B 23.75
EssilorLuxottica Societe Anonyme (ESLOY) France $28.260B 0.00
ResMed (RMD) United States $25.025B 36.34
Sunny Optical Technology (SNPTF) China $20.071B 0.00
Smith & Nephew SNATS (SNN) United Kingdom $17.905B 0.00
Bio-Rad Laboratories (BIO) United States $14.731B 66.62
Insulet (PODD) United States $13.054B 552.33
Shandong Weigao Medical Polymer (SHWGF) China $12.315B 0.00
DiaSorin S.p.A (DSRLF) Italy $11.312B 0.00
Quidel (QDEL) United States $9.631B 51.02
GN STORE NORD (GNNDY) Denmark $8.157B 41.58
William Demant Holdings (WILYY) Denmark $7.457B 0.00
Perrigo (PRGO) Ireland $7.229B 12.40
Hill-Rom Holdings (HRC) United States $6.398B 15.88
Canopy Growth (CGC) Canada $6.287B 0.00
Hutchison China MediTech (HCM) Hong Kong, SAR China $4.378B 0.00
Neogen (NEOG) United States $4.135B 69.09
Haemonetics (HAE) United States $4.050B 26.99
ICU Medical (ICUI) United States $4.048B 30.88
Envista Holdings (NVST) United States $3.688B 25.15
Abcam (ABCZY) $3.604B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.409B 0.00
National Vision Holdings (EYE) United States $2.831B 440.00
Agios Pharmaceuticals (AGIO) United States $2.792B 0.00
NuVasive (NUVA) United States $2.755B 38.40
DFB Healthcare Acquisitions (AHCO) United States $2.045B 188.38
TG Therapeutics (TGTX) United States $2.036B 0.00
AtriCure (ATRC) United States $1.843B 0.00
MacroGenics (MGNX) United States $1.447B 0.00
NanoString Technologies (NSTG) United States $1.356B 0.00
Aphria (APHA) Canada $1.281B 0.00
Aurora Cannabis (ACB) Canada $1.157B 0.00
Cerus (CERS) United States $1.138B 0.00
Cardiovascular Systems (CSII) United States $1.096B 0.00
InMode (INMD) Israel $0.995B 25.10
OraSure Technologies (OSUR) United States $0.960B 0.00
Quanterix (QTRX) United States $0.950B 0.00
Owens & Minor (OMI) United States $0.945B 21.17
Lantheus Holdings (LNTH) United States $0.914B 12.67
Omeros (OMER) United States $0.866B 0.00
PetIQ (PETQ) United States $0.832B 24.04
Phibro Animal Health (PAHC) United States $0.790B 15.76
Vapotherm (VAPO) United States $0.742B 0.00
Surmodics (SRDX) United States $0.645B 70.73
VAREX IMAGING (VREX) United States $0.637B 15.81
BioLife Solutions (BLFS) United States $0.634B 330.33
Zynex (ZYXI) United States $0.623B 54.39
Eagle Pharmaceuticals (EGRX) United States $0.587B 82.92
LeMaitre Vascular (LMAT) United States $0.586B 35.79
Cytosorbents (CTSO) United States $0.401B 0.00
Viemed Healthcare (VMD) United States $0.399B 14.25
Neptune Wellness Solutions (NEPT) Canada $0.343B 0.00
HEXO (HEXO) $0.327B 0.00
Utah Medical Products (UTMD) $0.300B 25.71
InfuSystems Holdings (INFU) United States $0.258B 143.11
Organigram Holdings (OGI) Canada $0.234B 0.00
Female Health (VERU) United States $0.207B 0.00
Chimerix (CMRX) United States $0.184B 0.00
Exagen (XGN) United States $0.181B 0.00
Bovie Medical (APYX) United States $0.178B 0.00
Fonar (FONR) United States $0.171B 15.14
Surface Oncology (SURF) United States $0.168B 0.00
Wound Management Technologies (SMTI) United States $0.167B 0.00
Liberty Health Sciences (LHSIF) Canada $0.128B 0.00
Evolus (EOLS) United States $0.126B 0.00
Green Organic Dutchman Holdings (TGODF) Canada $0.125B 0.00
Rockwell Medical (RMTI) United States $0.122B 0.00
Chembio Diagnostics (CEMI) United States $0.108B 0.00
Capricor Therapeutics (CAPR) United States $0.096B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
MTech Acquisition (KERN) United States $0.087B 0.00
United-Guardian (UG) United States $0.073B 16.35
Nephros (NEPH) United States $0.071B 0.00
Brainsway (BWAY) Israel $0.068B 0.00
Trinity Biotech (TRIB) Ireland $0.060B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
GUARDION HEALTH (GHSI) United States $0.037B 0.00
Akers Biosciences Inc (AKER) United States $0.033B 0.00
FSD PHARMA INC (HUGE) Canada $0.026B 0.00
NF Energy Saving (BIMI) China $0.021B 0.00
Myomo (MYO) United States $0.011B 0.00
Conatus Pharmaceuticals (HSTO) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 0.00
Senestech (SNES) United States $0.007B 0.00